Phase 3 RCT of 205 patients with locally advanced oropharyngeal cancer: IMPT vs IMRT did not differ significantly in 12-month feeding-tube dependence or severe weight loss (OR 2.80, p=0.079) or physical quality of life (78.3 vs 77.1); survival was similar.
RCTn = 205
Thomson et al. Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial